Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
2351 participants
OBSERVATIONAL
2012-11-30
2013-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Apparently healthy subjects
No interventions assigned to this group
Non-malignant conditions subjects
No interventions assigned to this group
Malignant conditions subjects
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* normal appearance of sample
* minimum 0.5 ml volume available
Exclusion Criteria
* insufficient volume
* insufficient clinical information
* \> 3 freeze/thaw cycles of samples
* Stored or shipped at \> 0°C
* Icteric, lipemic, hemolytic, substantial particulates
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Chinese PLA General Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yaping Tian
Director of Biochemistry Department
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
China PLA General Hospital
Beijing, , China
The First Affiliated Hospital of Fujian Medical University
Fuzhou, , China
Sun Yat-Sen University Cancer Center
Guangzhou, , China
Shandong University Qilu Hospital
Jinan, , China
Fudan University Shanghai Cancer Center
Shanghai, , China
Tianjin Cancer Hospital
Tianjin, , China
Xinjiang Medical University Cancer Center
Ürümqi, , China
Tongji Hospital Tongji Medical Colege of HUST
Wuhan, , China
Zhongshan Hospital Xiamen University
Xiamen, , China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CIM RD001
Identifier Type: -
Identifier Source: org_study_id